Advertisement
Advertisement
U.S. markets open in 2 hours 10 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Rubius Therapeutics, Inc. (RUBY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8878-0.0323 (-3.51%)
At close: 04:00PM EDT
0.8854 -0.00 (-0.27%)
After hours: 07:14PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close0.9201
Open0.9000
Bid0.0000 x 800
Ask0.0000 x 900
Day's Range0.8819 - 0.9479
52 Week Range0.7500 - 24.8400
Volume229,142
Avg. Volume1,625,763
Market Cap80.219M
Beta (5Y Monthly)2.86
PE Ratio (TTM)N/A
EPS (TTM)-2.2980
Earnings DateAug 08, 2022 - Aug 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RUBY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rubius Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/25/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
Advertisement
Advertisement